Besides, our list also included 23 star-alleles of the Cytochrome P450 (CYP) superfamily, the NAT2 gene, and 11 HLA alleles have been reported to be associated with differential responses to drugs used for COVID-19 treatment at different levels (Table S2). This evidence concerns the gene NAT2 and COVID-19.